bifonazole
This page covers all bifonazole drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Indoleamine 2,3-dioxygenase 1, Lanosterol 14-alpha demethylase, Cytochrome P450 3A4.
Targets
Indoleamine 2,3-dioxygenase 1, Lanosterol 14-alpha demethylase, Cytochrome P450 3A4
Phase 3 pipeline (1)
- Bifazol · Infectious Disease
Bifazol works by inhibiting the enzyme steroid 17-alpha-hydroxylase/17,20 lyase, which is involved in the production of steroids in the body.
Patent intelligence
- bifonazole patent landscape — aggregated cliff calendar, attackable patents, originator estates